Check the spelling or try searching for a more general term.
Our ongoing vision is to transform outcomes and quality of life for patients — safely, accurately, effectively and consistently.
Equally as importantly, we’re committed to developing solutions that enable ophthalmologists to focus on proactive patient care through earlier intervention to achieve better results — sustainably and naturally.
Find out more about how we’re achieving new breakthroughs for patients.
Helping physicians to prioritize proactive care
Combatting, restoring — naturally
Quantel Medical has completed its acquisition of Ellex, including the company’s laser and ultrasound technology solutions (with the exception of 2RT® and iTrack®), via the financial holding company Lumibird Medical.
The coming together of these two companies—both renowned in the field of ophthalmology—represents a real milestone in their history. Quantel Medical and Ellex have a shared heritage in the development of cutting-edge technologies for the diagnosis and treatment of the leading causes of blindness worldwide: glaucoma, cataracts, AMD and diabetic retinopathy.